Ocean Biomedical, Inc.
OCEA
$0.04
-$0.0015-3.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 91.72% | 73.00% | 60.10% | 65.06% | -559.40% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -55.50% | -100.00% | -100.00% | -- | -- |
| Total Other Non-Cash Items | -96.15% | -72.51% | -60.81% | -71.31% | 661.44% |
| Change in Net Operating Assets | -11.69% | -88.44% | 33.04% | -107.41% | -57.96% |
| Cash from Operations | 55.67% | 70.61% | 64.96% | -121.64% | -849.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -61.83% | -79.84% | -90.91% | 379.37% | 1,111.97% |
| Total Debt Repaid | -- | 100.00% | 100.00% | -181.82% | -- |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.92% | 100.93% | 112.88% | -4,698.71% |
| Cash from Financing | -67.30% | -81.76% | -91.33% | 127.16% | 975.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.41% | -186.45% | -209.46% | 1,421.43% | 3,830.77% |